These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7855253)

  • 21. Bimonthly update. Therapy and clinical trials.
    Mistry PD; Elkeles RS
    Curr Opin Lipidol; 2000 Aug; 11(4):445-6. PubMed ID: 10945729
    [No Abstract]   [Full Text] [Related]  

  • 22. Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Carroll C; Tappenden P; Rafia R; Hamilton J; Chambers D; Clowes M; Durrington P; Qureshi N; Wierzbicki AS
    Pharmacoeconomics; 2017 May; 35(5):537-547. PubMed ID: 28285379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy and clinical trials.
    Ogunko A; Evans M
    Curr Opin Lipidol; 1998 Dec; 9(6):617-8. PubMed ID: 10075483
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood cholesterol lowering.
    Crouch MA
    J Am Board Fam Pract; 1991; 4(3):195-8. PubMed ID: 2053460
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of megatrials with antihyperlipidemic agents in Japan].
    Fukai S; Ouchi Y
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():270-4. PubMed ID: 17821901
    [No Abstract]   [Full Text] [Related]  

  • 26. Needed: pragmatic clinical trials for statin-intolerant patients.
    Maningat P; Breslow JL
    N Engl J Med; 2011 Dec; 365(24):2250-1. PubMed ID: 22085320
    [No Abstract]   [Full Text] [Related]  

  • 27. Underutilization of lipid-lowering therapy in coronary artery disease.
    Batalla A; Hevia S; Reguero JR; Cubero GI
    Arch Intern Med; 2000 Sep; 160(17):2683-4. PubMed ID: 10999994
    [No Abstract]   [Full Text] [Related]  

  • 28. Reducing high blood cholesterol levels with drugs.
    JAMA; 1991 Apr; 265(15):1949-50. PubMed ID: 1901096
    [No Abstract]   [Full Text] [Related]  

  • 29. Simplifying the approach to the management of dyslipidemia.
    Gaziano JM; Gaziano TA
    JAMA; 2009 Nov; 302(19):2148-9. PubMed ID: 19920241
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 31. Poor adherence with hypolipidemic drugs: a lost opportunity.
    Tsuyuki RT; Bungard TJ
    Pharmacotherapy; 2001 May; 21(5):576-82. PubMed ID: 11349746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of first authorizations for lipid-lowering drugs in Belgium.
    Devroey D; Betz W
    Acta Clin Belg; 2003; 58(3):152-8. PubMed ID: 12945474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels.
    Roberts WC
    Am J Cardiol; 1994 Mar; 73(8):623-4. PubMed ID: 8147319
    [No Abstract]   [Full Text] [Related]  

  • 34. Reducing expenditures for statin-type lipid-lowering agents.
    Am J Health Syst Pharm; 1998 May; 55(10):995-6, 999. PubMed ID: 9606450
    [No Abstract]   [Full Text] [Related]  

  • 35. [A new approach to the treatment of dyslipidemia].
    Kevelaitiene S; Slapikas R
    Medicina (Kaunas); 2008; 44(5):407-13. PubMed ID: 18541958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.
    McCrindle BW; Urbina EM; Dennison BA; Jacobson MS; Steinberger J; Rocchini AP; Hayman LL; Daniels SR; ; ;
    Circulation; 2007 Apr; 115(14):1948-67. PubMed ID: 17377073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for Clinical Evaluation, Development, and Regulation of Lipid-Acting Anti-Atherosclerosis Agents.
    Am J Cardiol; 1998 Apr; 81(8A):1F-94F. PubMed ID: 9634423
    [No Abstract]   [Full Text] [Related]  

  • 38. [Summary of the 'Cholesterol' guideline (first revision) of the Dutch College of Family Practice].
    Bonneux L
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):862-3. PubMed ID: 10816777
    [No Abstract]   [Full Text] [Related]  

  • 39. The reply.
    Boyden TF
    Am J Med; 2015 Oct; 128(10):e75. PubMed ID: 26387006
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapy and clinical trials.
    Cramb R
    Curr Opin Lipidol; 1998 Aug; 9(4):381-3. PubMed ID: 9739497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.